NEXVOUND
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99509702
- Mark type
- Design + words
- Filed
- 21 Nov 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical information services in the field of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, psoriasis, rheumatoid arthritis, weight management, ulcerative colitis, and vascular diseases
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Jan 2026 — ASSIGNED TO EXAMINER
- 17 Dec 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 17 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Nov 2025 — NEW APPLICATION ENTERED